Sanofi's net rises 54% on growth of core businesses
Article Abstract:
Sanofi-Synthelabo SA posted an increase of 54% in its net profits for the 2000 year. The company posted 961 million euros in net earnings for the year.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Merck's net rises despite lag in sales of arthritis drug
Article Abstract:
Merck and Co. posted an increase of 11% in its 2001 first-quarter net income. The company, which posted disappointing sales of its Vioxx arthritis drug, posted $1.66 billion (1.84 billion euros) in quarterly net income.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Aventis posts 31% increase in net, raises its targets for full year
Article Abstract:
Aventis S.A. posted an increase of 31% in its net profits for the 2001 second-quarter. The company posted 391 million euros in net profits for its core pharmaceutical business.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Vivendi Universal posts a 60% rise in net, expects to top latest targets. Vivendi posts a record loss for second year
- Abstracts: Aerospace merger news lifts shares of principals in mostly weak session. DaimlerChrysler launches 6.5 billion euros jumbo issue
- Abstracts: Malaysia's Sime Darby makes 269 million euros offer for Palmco. Softbank venture opens a hub office in Malaysia
- Abstracts: Accident raises safety concerns on Chinese tires: up to 450,000 imports may contain a defect; obstacles to a recall
- Abstracts: L&H's restructuring plan weighs against shareholders (Lernout and Hauspie Speech Products N.V.). Lernout and Hauspie seeks bankruptcy protection